YOLFTbeta
00

Ahn-Gook Pharmaceutical Co. Ltd

001540 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

9,530.00KRW+160.00 (+1.71%)

Price History

Full chart

Market Stats

Previous Close9,370.00
Open9,370.00
Day Range9,370.00 – 9,620.00
52-Week Range6,949.24 – 13,650.00
Volume27.80K
Market Cap114.90B
P/E (TTM)0.00
Forward P/E8.15
Dividend Yield6.34%
Beta0.78
50-Day Avg10,826.60
200-Day Avg9,466.70

About

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. June-Sun Auh
  • Employees391
  • Headquarters613 Siheung -daero, Seoul, South Korea, Korea
  • Websitehttps://www.ahn-gook.com

Leadership

  • Mr. June-Sun AuhChairman and Co-Chief Executive Officer · b. 1937
  • Uh JinCo-Chief Executive Officer, President and Representative Director · b. 1964
  • Chang-Gyun HanExecutive Officer and Director · b. 1963

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue129.95B140.83B154.10B167.94B197.74B174.00B183.60B185.75B155.85B143.36B163.53B205.39B233.68B271.12B306.87B
Growth (%)-+8.37%+9.42%+8.98%+17.74%-12.00%+5.52%+1.17%-16.09%-8.01%+14.07%+25.59%+13.77%+16.02%+13.19%
Cost of Revenue63.24B77.09B83.46B95.90B116.63B103.62B91.42B87.96B77.86B58.47B62.52B79.11B93.10B103.22B106.57B
Gross Profit---69.77B81.11B70.39B92.18B97.79B77.99B84.89B101.02B126.28B140.57B167.90B200.30B
Gross Margin---41.55%41.02%40.45%50.21%52.65%50.04%59.22%61.77%61.48%60.16%61.93%65.27%
Operating Expense---59.97B69.31B67.84B81.94B82.81B77.13B84.95B102.10B117.11B135.57B161.41B190.48B
Operating Income9.19B5.49B10.13B9.80B11.80B2.55B10.24B14.97B862.28M-61.21M-1.08B9.17B5.00B6.48B9.82B
Operating Margin7.08%3.90%6.58%5.84%5.97%1.47%5.58%8.06%0.55%-0.04%-0.66%4.46%2.14%2.39%3.20%
EBITDA-----------12.47B9.43B30.94B19.25B
EBITDA Margin-----------6.07%4.04%11.41%6.27%
Net Income6.47B3.63B6.52B-1.37B9.36B1.72B8.16B13.22B2.54B-1.32B3.94B6.88B1.29B16.85B7.48B
Net Income Margin4.98%2.57%4.23%-0.81%4.74%0.99%4.44%7.12%1.63%-0.92%2.41%3.35%0.55%6.21%2.44%
R&D865.12M-17.44B21.31B213.50M104.38M84.00M77.11M116.09M16.99B17.33B12.96B12.25B13.26B26.90B
R&D as % of Total Revenue0.67%-11.32%12.69%0.11%0.06%0.05%0.04%0.07%11.85%10.60%6.31%5.24%4.89%8.76%
Interest Expense000000000756.89M116.83M160.41M142.75M3.00B2.75B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.53%0.07%0.08%0.06%1.11%0.90%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets163.85B167.83B163.24B179.07B197.85B196.27B208.07B212.92B217.96B201.70B211.80B223.91B238.60B302.54B310.95B
Total Liabilities51.77B53.47B36.82B56.61B66.79B65.37B71.11B66.16B69.71B57.60B66.54B69.11B86.93B136.86B144.66B
Total Equity111.52B113.62B125.89B121.73B131.06B130.89B136.96B146.77B148.25B144.10B145.26B154.80B152.09B165.68B165.37B
Cash4.95B8.42B4.36B5.46B19.17B21.38B22.63B21.47B22.74B11.21B2.87B10.34B28.99B6.07B38.95B
Total Debt----24.63B11.77B10.75B10.57B18.55B20.30B-----
Net Debt--------5.47B7.35B6.02B1.24B-61.46B33.53B

Cash Flow

Currency: KRW2002-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--11.51B3.64B1.29B19.11B12.62B17.46B-1.20B22.08B11.19B1.47B1.79B-1.33B4.91B45.68B
Investing Cash Flow-8.34B---728.86M-16.72B-7.27B-8.65B2.65B-27.59B-9.43B3.12B6.43B17.19B-75.39B-
Financing Cash Flow-2.59B310.79M-507.31M11.41B-3.23B-7.18B-2.82B6.66B-11.46B-3.85B-3.73B-5.09B57.20B-
Capital Expenditure02.26B2.58B6.60B7.16B2.33B4.38B4.79B2.91B3.74B24.12B4.04B2.93B5.47B75.89B8.67B
Free Cash Flow---------14.29B-13.30B-3.69B-1.99B-7.56B-71.39B37.01B
Dividends Paid-990.09M1.00B1.26B2.22B2.27B2.52B2.52B2.52B2.52B2.52B2.52B2.51B2.50B2.50B5.00B
FCF to OCF---------64.72%-118.86%-250.69%-111.26%569.06%-1452.68%81.03%
Dividend Paid to FCF---------17.64%-18.96%-68.31%-126.20%-33.09%-3.50%13.51%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Sep 30, 2013Dec 31, 2013Jun 30, 2014Dec 1, 2014Mar 13, 2015May 16, 2015Aug 18, 2015Nov 15, 2015Feb 11, 2016May 16, 2016Aug 16, 2016Nov 14, 2016Feb 21, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Feb 26, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 27, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------------------------------
EPS Actual361.70583.33108.26288.25404.48535.08126.67361.69351.97156.9899.428.94342.50313.0029.34-263.03259.70177.76230.02145.58190.70-489.23198.19372.35294.00-47.0074.42-55.4814.23118.39155.18222.00349.00-28.22152.77256.00223.00495.00131.26-118.47129.1479.00199.73-391.0722.8751.7197.90-151.35123.12274.25109.96104.93341.0947.95236.0861.2057.86-241.63686.20848.08-36.09-16.02315.47273.66296.11-227.041088.62747.52
Surprise--------------------------------------------------------------------
Timing--------------------Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-market--Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market------------------------------

Key Statistics & Ratios

Market Cap114.90B
Enterprise Value126.76B
Trailing P/E0.00
Forward P/E8.15
Price / Sales0.33
Price / Book0.64
Revenue (TTM)345.08B
Gross Profit (TTM)230.23B
EBITDA32.98B
Profit Margin6.28%
Operating Margin9.41%
Return on Equity12.63%
Return on Assets4.67%
Shares Outstanding11.37M
Shares Float5.08M
Beta0.78
Dividend Yield6.34%
Dividend Rate633.00
Payout Ratio33.22%

Dividends

20251×
633.00Dec 29, 2025
20241×
440.00Dec 27, 2024
20231×
220.00Dec 27, 2023
20221×
220.00Dec 28, 2022
20211×
220.00Dec 29, 2021
20201×
220.00Dec 29, 2020
20191×
220.00Dec 27, 2019
20181×
220.00Dec 27, 2018
20171×
220.00Dec 27, 2017
20161×
220.00Dec 28, 2016
20151×
220.00Dec 29, 2015
20141×
200.00Dec 29, 2014
20131×
198.02Dec 27, 2013
20121×
120.11Dec 27, 2012
20111×
95.14Dec 28, 2011
20101×
94.57Dec 29, 2010
20091×
94.00Dec 29, 2009
20081×
94.00Dec 29, 2008
20071×
94.00Dec 27, 2007
20061×
94.00Dec 27, 2006
20051×
94.00Dec 28, 2005
20041×
94.00Dec 29, 2004
20031×
94.00Dec 29, 2003
20021×
79.90Dec 27, 2002

Stock Splits

  • Dec 29, 2014101:100
  • Dec 27, 2013101:100
  • Oct 16, 2013858:841
  • Dec 27, 2012101:100
  • Dec 28, 2011503:500
  • Dec 29, 2010503:500
  • Sep 9, 200210:1